Press releases
- Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product
- Charles River Laboratories Announces Second-Quarter 2022 Results
- Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
- Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
- Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
- Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
- Charles River Laboratories to Participate in Jefferies and William Blair Conferences
More ▼
Key statistics
As of last trade, Charles River Laboratories International Inc (RV6:MUN) traded at 224.80, 14.58% above the 52 week low of 196.20 set on Jun 22, 2022.
52-week range
Markit short selling activity
Open | 224.80 |
---|---|
High | 224.80 |
Low | 224.80 |
Bid | 225.65 |
Offer | 228.35 |
Previous close | 217.70 |
Average volume | 8.00 |
---|---|
Shares outstanding | 50.86m |
Free float | 50.35m |
P/E (TTM) | 26.29 |
Market cap | 11.52bn USD |
EPS (TTM) | 8.62 USD |
Data delayed at least 15 minutes, as of Aug 15 2022 07:04 BST.
More ▼